by Stacey Johnson | Mar 31, 2015
. In May 2012, the Stem Cell Network (SCN) and the Centre for Commercialization of Regenerative Medicine (CCRM) launched Signals Blog, an evolution of SCN’s popular Stem Cell Network Blog and the brainchild of Lisa Willemse, Director of Communications at SCN. Beyond...
by Stacey Johnson | Mar 20, 2015
. American media and telecom billionaire John Malone, along with his horse-breeding wife Leslie, have generously donated U.S. $42.5 million to Colorado State University to launch the CSU Institute for Biologic Translational Therapies to develop regenerative medicine...
by Lisa Willemse | Mar 17, 2015
> Many of us only become acutely aware of our brain when it’s not working quite right. Like, say, if we have a migraine, or are diagnosed with a mental illness. Or we fall on the ice and give ourself a concussion that affects our vision, motor skills and...
by Stacey Johnson | Mar 6, 2015
. The beauty of an infographic (or two) is it speaks for itself. Shared with permission of BioInformant: http://www.bioinformant.com/ Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We...
by Mark Curtis | Feb 23, 2015
. Welcome to your deal review for the month of January. There was a mixed bag of news last month, which included financing activity, industry partnerships and research collaborations. The cell therapy tools industry was front and centre as NeoStem and Invetech struck...
by Mark Curtis | Feb 19, 2015
. Welcome to your Update from the Clinic for the month of January. Pluristem and OncoMed reported preliminary efficacy data from early-stage trials, while the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) granted a number of Orphan Drug...
Comments